Disease extent and response to chemotherapy in non-small cell lung cancer

被引：4

作者：

Satoh, H

Yano, H

Ishikawa, H

Hasegawa, S

机构：

[1] Department of Pulmonary Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-city

来源：

ACTA ONCOLOGICA | 1996年 / 35卷 / 01期

关键词：

D O I：

10.3109/02841869609098489

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：106 / 107

页数：2

共 9 条

[1] MITOMYCIN-IFOSFAMIDE-CISPLATINUM (MIP) VS MIP-INTERFERON VS CISPLATINUM-CARBOPLATIN IN METASTATIC NON-SMALL-CELL LUNG-CANCER - A FONICAP RANDOMIZED PHASE-II STUDY [J].

ARDIZZONI, A ;

ADDAMO, GF ;

BALDINI, E ;

BORGHINI, U ;

PORTALONE, L ;

DEMARINIS, F ;

LIONETTO, R ;

CONTE, PF ;

BRUZZI, P ;

PENNUCCI, MC ;

VENTURINI, M ;

RINALDI, M ;

ROSSO, R ;

SALVATI, F .

BRITISH JOURNAL OF CANCER, 1995, 71 (01) :115-119

[2]

DRINGS P, 1987, IFOSFAMIDE TUMOR THE, P294

[3] SYMPTOM RELIEF WITH MVP (MITOMYCIN-C, VINBLASTINE AND CISPLATIN) CHEMOTHERAPY IN ADVANCED NON-SMALL-CELL LUNG-CANCER [J].

ELLIS, PA ;

SMITH, IE ;

HARDY, JR ;

NICOLSON, MC ;

TALBOT, DC ;

ASHLEY, SE ;

PRIEST, K .

BRITISH JOURNAL OF CANCER, 1995, 71 (02) :366-370

[4] NEW AGENTS IN NON-SMALL CELL LUNG-CANCER [J].

JOSS, RA ;

CAVALLI, F ;

GOLDHIRSCH, A ;

MERMILLOD, B ;

BRUNNER, KW .

CANCER TREATMENT REVIEWS, 1984, 11 (03) :205-236

[5] RANDOMIZED COMPARISON OF 2 COMBINATION REGIMENS VERSUS MINIMAL CHEMOTHERAPY IN NONSMALL-CELL LUNG-CANCER - A SOUTHEASTERN CANCER STUDY-GROUP TRIAL [J].

LUEDKE, DW ;

EINHORN, L ;

OMURA, GA ;

SARMA, PR ;

BARTOLUCCI, AA ;

BIRCH, R ;

GRECO, FA .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (05) :886-891

[6]

MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO

[7]

2-6

[8] A PROGNOSTIC-FACTOR RISK INDEX IN ADVANCED NON-SMALL-CELL LUNG-CANCER TREATED WITH CISPLATIN-CONTAINING COMBINATION CHEMOTHERAPY [J].

SHINKAI, T ;

EGUCHI, K ;

SASAKI, Y ;

TAMURA, T ;

OHE, Y ;

KOJIMA, A ;

OSHITA, F ;

MIYA, T ;

OKAMOTO, H ;

IEMURA, K ;

SAIJO, N .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (01) :1-6

[9] CHEMOTHERAPY OF ADVANCED NON-SMALL-CELL LUNG-CANCER WITH CYCLOPHOSPHAMIDE, ADRIAMYCIN, METHOTREXATE, AND PROCARBAZINE VERSUS CISPLATIN AND ETOPOSIDE - A RANDOMIZED STUDY [J].

VERONESI, A ;

MAGRI, MD ;

TIRELLI, U ;

CARBONE, A ;

MAZZA, F ;

FRANCESCHI, S ;

TALAMINI, R ;

ARDIZZONI, A ;

CANOBBIO, L ;

ROSSO, R ;

MONFARDINI, S .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (05) :566-571

← 1 →